RETRACTED: The EQ-5D-5L Valuation Study in Egypt (Retracted Article)

被引:9
|
作者
Al Shabasy, Sahar A. [1 ]
Abbassi, Maggie M. [1 ]
Finch, Aureliano Paolo [2 ]
Baines, Darrin [3 ]
Farid, Samar F. [1 ]
机构
[1] Cairo Univ, Dept Clin Pharm, Fac Pharm, Kasr El Aini St, Cairo 11562, Egypt
[2] EuroQol Grp Off, Rotterdam, Netherlands
[3] Bournemouth Univ, Business Sch, Dorset House Talbot Campus, Poole, Dorset, England
关键词
TIME TRADE-OFF; VALUE SET; HEALTH STATES; EUROQOL; UTILITIES;
D O I
10.1007/s40273-021-01002-z
中图分类号
F [经济];
学科分类号
02 ;
摘要
Introduction No value sets exist for either the EQ-5D-3L or the EQ-5D-5L in Egypt, despite local pharmacoeconomic guidelines recommending the use of the EQ-5D to derive utility. Most published Egyptian economic evaluation studies have used utility values from other published studies and systematic reviews. Objective Our objective was to develop an Egyptian EQ-5D-5L value set using the international EuroQol standardized protocol (EQ-VT-2.1). Methods Adult Egyptian participants were recruited from public places using multi-stratified quota sampling based on age, sex, and geographical distribution. Two elicitation techniques were applied: the composite time trade-off (cTTO) and discrete-choice experiments (DCEs). Before actual data collection, interviewers' performance was assessed in a pilot phase. Data were modelled using generalized least square, Tobit, heteroskedastic, logit, and hybrid models, and the best fitting model was selected based on the value range between observed and predicted values, logical consistency of the parameters, significance level, and prediction accuracy. Results A total of 1378 interviews were conducted, of which 188 were excluded because they were incomplete or did not comply with protocol, 216 were pilot interviews, and 974 were included in the final analysis. The heteroskedastic model (model 4) based on the cTTO data was selected as the preferred model to generate the value set. Values ranged from - 0.93 for the worst health state (55555) to 1 for full health (11111), with 1136 (36.3%) of all predicted health states being worse than dead. Mobility had the largest impact on health state preference values. Conclusion This is the first value set for the EQ-5D-5L based on social preferences obtained from a nationally representative sample in Egypt or any Arabic-speaking country. The value set can be used as a scoring system for economic evaluations and to improve the quality of health technology assessment in the Egyptian healthcare system.
引用
收藏
页码:549 / 561
页数:13
相关论文
共 50 条
  • [1] RETRACTED ARTICLE: The EQ-5D-5L Valuation Study in Egypt
    Sahar A. Al Shabasy
    Maggie M. Abbassi
    Aureliano Paolo Finch
    Darrin Baines
    Samar F. Farid
    [J]. PharmacoEconomics, 2021, 39 : 549 - 561
  • [2] The EQ-5D-5L Valuation Study in Egypt
    Sahar Al Shabasy
    Maggie Abbassi
    Aureliano Finch
    Bram Roudijk
    Darrin Baines
    Samar Farid
    [J]. PharmacoEconomics, 2022, 40 : 433 - 447
  • [3] The EQ-5D-5L Valuation Study in Egypt
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    [J]. PHARMACOECONOMICS, 2022, 40 (04) : 433 - 447
  • [4] Retraction Note to: The EQ-5D-5L Valuation Study in Egypt
    Sahar A. Al Shabasy
    Maggie M. Abbassi
    Aureliano Paolo Finch
    Darrin Baines
    Samar F. Farid
    [J]. PharmacoEconomics, 2021, 39 : 971 - 971
  • [5] EQ-5D-5L valuation study for Portugal
    Ferreira, Pedro L.
    Antunes, Patricia
    Ferreira, Lara N.
    Pereira, Luis N.
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87
  • [6] The EQ-5D-5L valuation study in Korea
    Seon-Ha Kim
    Jeonghoon Ahn
    Minsu Ock
    Sangjin Shin
    Jooyeon Park
    Nan Luo
    Min-Woo Jo
    [J]. Quality of Life Research, 2016, 25 : 1845 - 1852
  • [7] EQ-5D-5L VALUATION STUDY IN TAIWAN
    Lin, H.
    Li, C.
    Lin, F.
    Chang, J.
    Gau, C.
    Luo, N.
    Pickard, A. S.
    Goni, Ramos J. M.
    Tang, C.
    Hsu, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S91 - S91
  • [8] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558
  • [9] The EQ-5D-5L valuation study in Korea
    Kim, Seon-Ha
    Ahn, Jeonghoon
    Ock, Minsu
    Shin, Sangjin
    Park, Jooyeon
    Luo, Nan
    Jo, Min-Woo
    [J]. QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1845 - 1852
  • [10] Valuation of the EQ-5D-5L in Taiwan
    Lin, Hsiang-Wen
    Li, Chia-Ing
    Lin, Fang-Ju
    Chang, Jen-Yu
    Gau, Churn-Shiouh
    Luo, Nan
    Pickard, A. Simon
    Goni, Juan M. Ramos
    Tang, Chao-Hsiun
    Hsu, Chien-Ning
    [J]. PLOS ONE, 2018, 13 (12):